LZFIWAYOZYIQLL-LREBCSMRSA-N
C29H34ClF3N4O7S — CID 159499649
Data last refreshed: (MolForge compound catalog, from PubChem)
About LZFIWAYOZYIQLL-LREBCSMRSA-N
LZFIWAYOZYIQLL-LREBCSMRSA-N (PubChem CID 159499649) has the molecular formula C29H34ClF3N4O7S and a molecular weight of 675.13 g/mol. Its IUPAC name is 1-[2-[4-[(2-chloro-4,4-difluorospiro[5H-thieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methylpyrazol-1-yl]-3-fluorophenyl]-N,N-dimethylmethanamine;(2R,3R)-2,3-dihydroxybutanedioic acid.
Molecular Properties
| Compound Name | LZFIWAYOZYIQLL-LREBCSMRSA-N |
|---|---|
| PubChem CID | 159499649 |
| Molecular Formula | C29H34ClF3N4O7S |
| Molecular Weight | 675.13 g/mol |
| Exact Mass | 674.18 |
| IUPAC Name | 1-[2-[4-[(2-chloro-4,4-difluorospiro[5H-thieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methylpyrazol-1-yl]-3-fluorophenyl]-N,N-dimethylmethanamine;(2R,3R)-2,3-dihydroxybutanedioic acid |
| SMILES | Cc1nn(-c2c(F)cccc2CN(C)C)cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O |
| InChI | InChI=1S/C25H28ClF3N4OS.C4H6O6/c1-16-18(14-33(30-16)22-17(12-31(2)3)5-4-6-20(22)27)13-32-9-7-24(8-10-32)23-19(11-21(26)35-23)25(28,29)15-34-24;5-1(3(7)8)2(6)4(9)10/h4-6,11,14H,7-10,12-13,15H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 |
| InChIKey | LZFIWAYOZYIQLL-LREBCSMRSA-N |
| XLogP | 3.59 |
| TPSA | 148.59 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 675.13 |
| LogP ≤ 5 | 3.59 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159499649 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.